Elucidation of the Pathophysiology of CholesteHelp and Puberulic Acid Nephropathy

Background: In March 2024, health problems caused by a supplement made from red yeast rice (Cholestehelp) were reported in Japan. By November 24, 2024, 2,628 people had visited medical facilities, resulting in a social problem. Even among patients who have recovered, many still have partial kidney damage and a decline in eGFR. The previous report, however, did not indicate anything other than that puberulic acid which newly identified nephrotoxicity was contained in toxic lot. We need to reveal the pathophysiology of those Nephropathies. Methods: We established the model of Cholestehelp / puberulic acid nephropathy with mice, human-derived tubular organoids and human primary epithelial cells, then analyzed them through RNA-seq, Western Blotting, Immunostaining, and Flow cytometry. Results: We administered PBS, normal lot of Cholestehelp, toxic lot of that, and puberulic acid by oral gavage or intraperitoneal injection to wild-type B6 mice (N= 10) for 6 days and then sacrificed them on day 7. The mice treated with the toxic lot and puberulic acid showed weight loss, renal dysfunction, albuminuria, elevated urinary NAG and urinary glucose, which is consistent with Fanconi syndrome. In addition, pathological sections showed tubular necrosis and interstitial fibrosis. We performed analyses of RNA-seq on whole kidneys of those mice. The renal damage caused by Cholestehelp and puberulic acid produced similar RNA patterns. Gene Ontology (GO) analysis comparing the normal and toxic lot revealed downregulation of mitochondrial-related pathways, including oxidative phosphorylation, aerobic respiration and so on. Puberulic acid also showed toxicity on human primary epithelial cells and tubular organoids. EC50 of puberulic acid is approximately twice that of cisplatin. In vitro experiments with human primary cells, revealed that it causes ATP deficiency and mitochondrial damage at first and leads to cell death. Annexin V assay presented the cell death was mainly necrosis with relatively little apoptosis. Conclusion: Puberulic acid was confirmed as the causative agent for CholesteHelp nephropathy. Both cause direct mitochondrial damage induced by ATP depletion on tubular epithelial cells, followed by necrosis rather than apoptosis.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025r0w7m53b
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Elucidation of the Pathophysiology of CholesteHelp and Puberulic Acid Nephropathy

Eisei Sohara, Takayasu Mori, Yutaro Mori, Yuta Sekiguchi et al.
Journal of the American Society of Nephrology
Liver Diseases and Immunity
article

Elucidation of the Pathophysiology of CholesteHelp and Puberulic Acid Nephropathy

Eisei Sohara, Takayasu Mori, Yutaro Mori, Yuta Sekiguchi, Shintaro Mandai, Makiko Mori, Fumiaki Ando, Hiroaki Kikuchi, Yuki Nakao, Koichiro Susa, Shinichi Uchida
article en

Abstract

Background: In March 2024, health problems caused by a supplement made from red yeast rice (Cholestehelp) were reported in Japan. By November 24, 2024, 2,628 people had visited medical facilities, resulting in a social problem. Even among patients who have recovered, many still have partial kidney damage and a decline in eGFR. The previous report, however, did not indicate anything other than that puberulic acid which newly identified nephrotoxicity was contained in toxic lot. We need to reveal the pathophysiology of those Nephropathies. Methods: We established the model of Cholestehelp / puberulic acid nephropathy with mice, human-derived tubular organoids and human primary epithelial cells, then analyzed them through RNA-seq, Western Blotting, Immunostaining, and Flow cytometry. Results: We administered PBS, normal lot of Cholestehelp, toxic lot of that, and puberulic acid by oral gavage or intraperitoneal injection to wild-type B6 mice (N= 10) for 6 days and then sacrificed them on day 7. The mice treated with the toxic lot and puberulic acid showed weight loss, renal dysfunction, albuminuria, elevated urinary NAG and urinary glucose, which is consistent with Fanconi syndrome. In addition, pathological sections showed tubular necrosis and interstitial fibrosis. We performed analyses of RNA-seq on whole kidneys of those mice. The renal damage caused by Cholestehelp and puberulic acid produced similar RNA patterns. Gene Ontology (GO) analysis comparing the normal and toxic lot revealed downregulation of mitochondrial-related pathways, including oxidative phosphorylation, aerobic respiration and so on. Puberulic acid also showed toxicity on human primary epithelial cells and tubular organoids. EC50 of puberulic acid is approximately twice that of cisplatin. In vitro experiments with human primary cells, revealed that it causes ATP deficiency and mitochondrial damage at first and leads to cell death. Annexin V assay presented the cell death was mainly necrosis with relatively little apoptosis. Conclusion: Puberulic acid was confirmed as the causative agent for CholesteHelp nephropathy. Both cause direct mitochondrial damage induced by ATP depletion on tubular epithelial cells, followed by necrosis rather than apoptosis.

Journal of the American Society of NephrologyVol. 36(10S)
Tokyo Kasei University (JP)
Openalex Percentile: Top 60%
Liver Diseases and Immunity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.